Asia Pacific Stem Cell Market Forecast 2018-2026

Publisher Name :
Date: 27-Jul-2018
No. of pages: 87

Key Findings

The Asia-Pacific stem cell market is anticipated to rise with the fastest CAGR of 10.13% over the projected years of 2018-2026. Chronic diseases like cancers have seen a considerable rise in the Asia-Pacific region. As a result, the demand for stem cell market is further expected to rise in this region.

Market Insights

The China stem cell market contributed the highest revenue share in 2017. A growing elderly population and fundamental progress in clinical stem cell research are factors which are majorly driving this country's growth. The other countries analyzed in this report include India, Japan, South Korea and a few others in the rest of Asia-Pacific. Among these, a significant growth is expected from the Japan stem cell market. Japan currently plays a significant role in the cancer stem cells market in the Asia-Pacific region and the Japanese government is heavily investing in the healthcare industry in order to improve the healthcare facilities in the country.

Competitive Insights

Some of the leading players in this market are Stemedica Cell Technologies Inc, Cellular Engineering Technologies Inc, Biotime Inc, Kangstem Biotech Ltd, Becton Dickinson, Cytori Therapeutics, Cellular Dynamics International (Holding Company Fujifilm), Thermo Fisher Vericel Corporation, Fibrocell Science Inc, Brainstorm Cell Therapeutics, Takara Holdings Inc., and Ge Healthcare.

Asia Pacific Stem Cell Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Regenerative Medicine Is The Emerging Branch of Medical Science
3.2.2. Use of Adult Stem Cells Has Been Significant
4. Market Determinants
4.1. Market Driver
4.1.1. Potential of Stem Cells In Regenerative Medicine
4.1.2. Key To Anti-Ageing And Prolonging Life
4.1.3. Increasing R&D Investments In Adult Stem Cell Research
4.1.4. Ease of Administration
4.1.5. Reduced Risk of Tissue Rejection In Transplants
4.2. Market Restraints
4.2.1. Safety Issues
4.2.2. Ethical Issues
4.3. Opportunities
4.3.1. Technological Innovations
4.3.2. Emerging Application As A Drug Discovery Tool
4.3.3. Other Promising Applications
4.4. Market Challenges
4.4.1. Stringent Government Regulations
4.4.2. Less Responsiveness In The Developed Economies
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Adult Stem Cell Market
5.1.1.1. Hematopoietic Stem Cell Market
5.1.1.2. Mesenchymal Stem Cell Market
5.1.1.3. Neural Stem Cell Market
5.1.1.4. Dental Stem Cell Market
5.1.1.5. Umbilical Cord Stem Cell Market
5.1.2. Human Embryonic Stem Cell
5.1.3. Induced Pluripotent Stem Cell Market
5.1.4. Rat Neural Stem Cell Market
5.2. Market By Technology 2018-2026
5.2.1. Stem Cell Acquisition
5.2.1.1. Stem Cell Bone Marrow Market
5.2.1.2. Stem Cell Apheresis Market
5.2.1.3. Umbilical Cord Blood Market
5.2.2. Stem Cell Production
5.2.2.1. Therapeutic Cloning
5.2.2.2. Ivf Stem Cell
5.2.2.3. Stem Cell Culture
5.2.3. Stem Cell Cryopreservation
5.2.4. Stem Cells Expansion And Sub-Culture
5.3. Market By Application 2018-2026
5.3.1. Regenerative Medicine
5.3.2. Drug Discovery And Development
6. Key Analytics
6.1. Porter's Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitute Products Or Services
6.1.3. Bargaining Power of Buyer
6.1.4. Bargaining Power of Supplier
6.1.5. Intensity of Competitive Rivalry
6.2. Value Chain Analysis
6.3. Opportunity Matrix
6.4. Key Buying Criteria
6.4.1. High Price
6.4.2. Efficacy
6.4.3. Application And Effectiveness
6.4.4. Accuracy
6.5. Pest Analysis
6.6. History of Stem Cell
6.7. Patent Analysis
6.7.1. Stem Cell Patent In Asia Pacific
6.8. Regulatory Framework
7. Geographical Analysis
7.1. Asia Pacific (Apac)
7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. South Korea
7.1.5. Rest of Asia Pacific (Roapac)
8. Company Profile
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Becton Dickinson
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Biotime Inc
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Brainstorm Cell Therapeutics
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Celgene Corporation
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Cellular Dynamics International (Holding Company Fujifilm)
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Cellular Engineering Technologies Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Corestem Inc
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Corning Inc.
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Cytori Therapeutics
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Fibrocell Science Inc
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Ge Healthcare
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Kangstem Biotech Ltd
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Strategic Initiatives
8.14. Stemedica Cell Technologies Inc
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Strategic Initiatives
8.15. Stryker Corporation
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
8.16. Takara Holdings Inc.
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiatives
8.17. Thermo Fisher
8.17.1. Company Overview
8.17.2. Product Portfolio
8.17.3. Scot Analysis
8.17.4. Strategic Initiatives
8.18. Vericel Corporation (Formerly Aastrom Bioscience)
8.18.1. Company Overview
8.18.2. Product Portfolio
8.18.3. Scot Analysis
8.18.4. Strategic Initiatives

List of Tables

Table 1 Asia Pacific Stem Cell Market 2018-2026 ($ Million)
Table 2 Asia Pacific Stem Cells Market By Products 2018-2026 ($ Million)
Table 3 Asia Pacific Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Table 4 Asia Pacific Stem Cell Market In Adult Stem Cell By Types 2018-2026 ($ Million)
Table 5 Asia Pacific Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Table 6 Asia Pacific Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Table 7 Asia Pacific Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Table 8 Asia Pacific Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Table 9 Asia Pacific Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Table 10 Asia Pacific Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Table 11 Asia Pacific Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Table 12 Asia Pacific Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Table 13 Asia Pacific Stem Cell Market By Technology 2018-2026 ($ Million)
Table 14 Asia Pacific Stem Cell Market In Acquisition By Types 2018-2026 ($ Million)
Table 15 Asia Pacific Stem Cell Market In Acquisition 2018-2026 ($ Million)
Table 16 Asia Pacific Stem Cell Acquisition Market In Bone Marrow By Geography 2018-2026 ($ Million)
Table 17 Asia Pacific Stem Cell Acquisition Market In Cell Apheresis 2018-2026 ($ Million)
Table 18 Asia Pacific Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Table 19 Asia Pacific Stem Cell Market In Production By Types 2018-2026 ($ Million)
Table 20 Asia Pacific Stem Cell Market In Production 2018-2026 ($ Million)
Table 21 Asia Pacific Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Table 22 Asia Pacific Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Table 23 Asia Pacific Stem Cell Production Market In Stem Cell Culture 2018-2026 ($ Million)
Table 24 Asia Pacific Stem Cell Market In Stem Cell Cryopreservation 2018-2026 ($ Million)
Table 25 Asia Pacific Stem Cell Market In Stem Cell Expansion And Sub-Culture 2018-2026 ($ Million)
Table 26 Asia Pacific Stem Cells Market By Application 2018-2026 ($ Million)
Table 27 Asia Pacific Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Table 28 Asia Pacific Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Table 29 Asia Pacific Stem Cell Market By Country 2018-2026 ($ Million)
Figures List
Figure 1 Asia Pacific Stem Cell Market 2018-2026 ($ Million)
Figure 2 Asia Pacific Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Figure 3 Asia Pacific Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Figure 4 Asia Pacific Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Figure 5 Asia Pacific Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Figure 6 Asia Pacific Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Figure 7 Asia Pacific Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Figure 8 Asia Pacific Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Figure 9 Asia Pacific Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Figure 10 Asia Pacific Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Figure 11 Asia Pacific Stem Cell Market In Acquisition 2018-2026 ($ Million)
Figure 12 Asia Pacific Stem Cell Acquisition Market In Bone Marrow 2018-2026 ($ Million)
Figure 13 Asia Pacific Stem Cell Acquisition Market In Apheresis 2018-2026 ($ Million)
Figure 14 Asia Pacific Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Figure 15 Asia Pacific Stem Cell Market In Production 2018-2026 ($ Million)
Figure 16 Asia Pacific Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Figure 17 Asia Pacific Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Figure 18 Asia Pacific Stem Cell Production Market In Stem Cells Culture 2018-2026 ($ Million)
Figure 19 Asia Pacific Stem Cell Market In Stem Cells Cryopreservation 2018-2026 ($ Million)
Figure 20 Asia Pacific Stem Cell Market In Stem Cell Expansion And Sub-Culture 2018-2026 ($ Million)
Figure 21 Asia Pacific Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Figure 22 Asia Pacific Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Figure 23 India Stem Cell Market 2018-2026 ($ Million)
Figure 24 China Stem Cell Market 2018-2026($ Million)
Figure 25 Japan Stem Cell Market 2018-2026 ($ Million)
Figure 26 South Korea Stem Cell Market 2018-2026 ($ Million)
Figure 27 Rest of Apac Stem Cell Market 2018-2026($ Million)
Figure 28 Stem Cell Market Share Analysis of Key Players 2017 (%)
  • Global and China Stem Cell Assay Market Size, Status and Forecast 2020-2026
    Published: 13-Oct-2020        Price: US 3900 Onwards        Pages: 92
    Global Stem Cell Assay Scope and Market Size Stem Cell Assay market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into ......
  • (COVID-19 Version) Global Stem Cell Therapy Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 12-Oct-2020        Price: US 3000 Onwards        Pages: 125
    Summary The report forecast global Stem Cell Therapy market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Stem Cell Therapy industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Stem Cell Therapy by geography. ......
  • (COVID-19 Version) Global Autologous Cell Therapy Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 11-Oct-2020        Price: US 3000 Onwards        Pages: 98
    Summary The report forecast global Autologous Cell Therapy market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Autologous Cell Therapy industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Autologous Cell Ther......
  • Global Animal Stem Cell Therapy Market Growth 2020-2025
    Published: 08-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Animal Stem Cell Therapy market will register a 38.7%% CAGR in terms of revenue, the global market size will reach $ 112.3 million by 2025, from $ 30 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Animal Stem Cell Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Animal Stem Cell T......
  • Global Autologous Cell Therapy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 06-Oct-2020        Price: US 3400 Onwards        Pages: 120
    The Autologous Cell Therapy market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Autologous Cell Therapy market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Autologous Cell Therapy market. The report focuses on well-known providers in the global Autologous Cell Therapy industry, market segments, ......
  • Global and China Stem Cell Therapy for Diabetes and Related Conditions Market Size, Status and Forecast 2020-2026
    Published: 01-Oct-2020        Price: US 3900 Onwards        Pages: 97
    Global Stem Cell Therapy for Diabetes and Related Conditions Scope and Market Size Stem Cell Therapy for Diabetes and Related Conditions market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Diabetes and Related Conditions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue a......
  • Global and China Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2020-2026
    Published: 01-Oct-2020        Price: US 3900 Onwards        Pages: 96
    Global Stem Cell Therapy for Osteoarthritis Scope and Market Size Stem Cell Therapy for Osteoarthritis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. ......
  • Global and China Hematopoietic Stem Cells Transplantation (HSCT) Market Size, Status and Forecast 2020-2026
    Published: 01-Oct-2020        Price: US 3900 Onwards        Pages: 97
    Global Hematopoietic Stem Cells Transplantation (HSCT) Scope and Market Size Hematopoietic Stem Cells Transplantation (HSCT) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hematopoietic Stem Cells Transplantation (HSCT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for th......
  • Global Animal Stem Cell Therapy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 01-Oct-2020        Price: US 3400 Onwards        Pages: 106
    The Animal Stem Cell Therapy market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Animal Stem Cell Therapy market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Animal Stem Cell Therapy market. The report focuses on well-known providers in the global Animal Stem Cell Therapy industry, market segmen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs